Bicara Therapeutics, Inc. (BCAX)
18.72
-0.16
(-0.87%)
USD |
NASDAQ |
Dec 09, 16:00
18.72
0.00 (0.00%)
After-Hours: 16:39
Bicara Therapeutics Total Assets (Quarterly): 424.69M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc. | 208.73B |
| Oncotelic Therapeutics, Inc. | 28.16M |
| Dogwood Therapeutics, Inc. | 91.99M |
| CEL-SCI Corp. | 20.34M |
| AIM ImmunoTech, Inc. | 5.494M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 21.91M |
| Shareholders Equity (Quarterly) | 402.78M |
| Debt to Equity Ratio | 0.0049 |
| Current Ratio | 14.14 |
| Net Debt Paydown Yield | -0.03% |